| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 41,635 | 41,021 | 38,767 | 37,829 | | Cost of Revenue | 23,765 | 20,800 | 23,140 | 11,265 | | | Gross Profit | 17,870 | 20,221 | 15,627 | 26,564 | | | Operating Expenses | | Research Development | 8,744 | 10,315 | 10,338 | 10,837 | | Selling General and Administrative | 13,326 | 17,498 | 12,081 | 23,679 | | Non Recurring |
-
|
-
| 747 | (1,454) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,200) | (7,592) | (7,539) | (6,498) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 215 | 532 | 147 | (205) | | Earnings Before Interest And Taxes | (3,985) | (7,060) | (7,392) | (6,703) | | Interest Expense | 99 | 73 | 75 | 10 | | Income Before Tax | (4,084) | (7,133) | (7,467) | (6,713) | | Income Tax Expense | (245) | (175) | (44) | (161) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,839) | (6,958) | (7,423) | (6,552) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,839) | (6,958) | (7,423) | (6,552) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,839) | ($6,958) | ($7,423) | ($6,552) |
|
0.51% Nasdaq 
Income Statement
